基替代模式影响黄类-HSA结合:来自多光谱谱学和分子模拟的机制性见解
Ziang Zhao1, Xinyi Fang1, Yanbing Gao1
1School of Chemical Engineering, Sichuan University, Chengdu 610065, Sichuan, China.
Food chemistry
|November 1, 2025
概括
黄类化合物与人血清白蛋白 (HSA) 的结合会影响药物行为. 由于其结构,氨酸显示出最强的HSA亲和力,为设计更好的黄类疗法提供了洞察力.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 黄酸是植物化合物,与人血清白蛋白 (HSA) 有多种相互作用.
- 这些相互作用显著影响药物的药理动力学.
- 了解黄胺-HSA结合对于药物开发至关重要.
研究的目的:
- 为了研究三种黄素 (chrysin,baicalin,glycitein) 与HSA的结合机制.
- 为了将黄蛋白结构特征与结合亲和力和位点特异性相关联.
- 为了阐明黄酸结合对HSA稳定性和形状的影响.
主要方法:
- 多光谱分析包括时间分辨率,同步和稳定状态光,循环二极化,动态光散射和3D光.
- 分子模拟包括分子对接和分子动力学.
- 结合相互作用的热力学分析.
主要成果:
- 结合的特点是静态火,基态复合体形成,以及HSA.中的α-螺旋体含量增加.
- 黄化合物结合导致由键和范德瓦尔斯力驱动的自发相互作用,亲和力从弱到强 (Kb ≈ 10^3-10^5 M^-1).
- 氨酸表现出最高的亲和力,归因于其5,7-二基替代,而甘氨酸的异黄结构降低了亲和力;Sudlow site III被确定为主要的结合点.
结论:
- 黄酸的结构属性,包括基组模式和环连接性,决定了结合强度,位点特异性和HSA稳定性.
- 分子动力学模拟显示,黄酸结合会诱导HSA的形状收紧,增加螺旋性并减少灵活性.
- 这些发现为合理设计基于黄类药物的治疗方法和准确的药理动力学预测提供了必要的机制性见解.
相关概念视频
Factors Affecting Protein-Drug Binding: Protein-Related Factors
511
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
511
IR and UV–Vis Spectroscopy of Aldehydes and Ketones
7.3K
Infrared spectroscopy, also known as vibrational spectroscopy, is mainly used to determine the types of bonds and functional groups in molecules. In aldehydes and ketones, the carbonyl (C=O) bond shows an absorption around 1710 cm-1. The C=O bond vibration of an aldehyde occurs at lower frequencies than that of a ketone. In addition to the C=O absorption in an aldehyde, the aldehydic C–H bond also gives two peaks in the 2700–2800 cm-1 range. This absorption, coupled with the...
7.3K
Drug Distribution: Plasma Protein Binding
8.4K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.4K
Cooperative Allosteric Transitions
8.6K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.6K
Protein-Drug Binding: Determination Methods
610
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
610
Drug Binding to Blood Components
490
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
490


